A Szentivanyi. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adenosine Monophosphate/metabolismAdrenergic alpha-Antagonists/therapeutic useAdrenergic beta-Agonists/therapeutic useAdrenergic beta-Antagonists/therapeutic useAirway Obstruction/immunologyAnimalsAnuraAsthma/drug therapyAsthma/immunologyB-Lymphocytes/immunologyBinding SitesCatecholamines/therapeutic useCell Membrane/immunologyDermatitis, Atopic/drug therapyDihydroalprenolol/therapeutic useDihydroergotoxine/therapeutic useHumansHypersensitivity, Immediate/immunologyLymphocytes/immunologyRadioligand AssayT-Lymphocytes/immunology
Substances: See more » Adrenergic alpha-AntagonistsAdrenergic beta-AgonistsAdrenergic beta-AntagonistsCatecholaminesDihydroergotoxineAdenosine MonophosphateDihydroalprenolol
Year: 1980 PMID: 6101282 DOI: 10.1016/0091-6749(80)90170-0
Source DB: PubMed Journal: J Allergy Clin Immunol ISSN: 0091-6749 Impact factor: 10.793